Literature DB >> 314108

Heterogeneity of failure of visual acuity in Graves' disease.

Y Sachdev, J C Chatterji, R C Sharma.   

Abstract

The eye manifestations of Graves' disease are usually mild and self-limiting. Occasionally they follow a progressive course leading to visual loss and total blindness. The ocular manifestations bear no relationship to the metabolic state and may appear before, during or after onset of thyrotoxicosis. Characteristically they become evident at about the time of onset of hypermetabolism. Various factors responsible for the failure of visual acuity are discussed with case illustrations.

Entities:  

Mesh:

Year:  1979        PMID: 314108      PMCID: PMC2428115          DOI: 10.1136/pgmj.55.642.241

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  19 in total

1.  The severe eye changes of Graves' disease.

Authors:  S C WERNER
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

2.  Assay of the exophthalmos-producing substance in the serum of patients with progressive exophthalmos.

Authors:  B M DOBYNS; A WRIGHT; L WILSON
Journal:  J Clin Endocrinol Metab       Date:  1961-06       Impact factor: 5.958

3.  Pathogenesis and treatment of endocrine exophthalmos.

Authors:  R BRAIN
Journal:  Lancet       Date:  1959-01-17       Impact factor: 79.321

4.  Eye signs in Graves' disease.

Authors:  S TAYLOR
Journal:  Lancet       Date:  1960-11-26       Impact factor: 79.321

5.  Ocular changes in Graves' disease. A long-term follow-up study.

Authors:  I B HALES; F F RUNDLE
Journal:  Q J Med       Date:  1960-01

6.  The role of thyrotrophin in hyperthyroidism and exophthalmos.

Authors:  D D ADAMS; H D PURVES
Journal:  Metabolism       Date:  1957-01       Impact factor: 8.694

7.  Intractable exophthalmos in thyroid disease.

Authors:  J L POPPEN
Journal:  Postgrad Med       Date:  1953-08       Impact factor: 3.840

8.  Surgical treatment of hyperthyroidism.

Authors:  L W SLOAN
Journal:  N Y State J Med       Date:  1951-12-15

9.  Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.

Authors:  J M McKenzie; E P McCullagh
Journal:  J Clin Endocrinol Metab       Date:  1968-08       Impact factor: 5.958

10.  Orbital radiation for the ocular changes of Gravess' disease.

Authors:  J G Ravin; J C Sisson; W T Knapp
Journal:  Am J Ophthalmol       Date:  1975-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.